Combined use of zoledronic acid and 153Sm-EDTMP in hormone-refractory prostate cancer patients with bone metastases.

Authors:
Lam MG; Dahmane A; Stevens WH; van Rijk PP; de Klerk JM and 1 more

Journal:
Eur J Nucl Med Mol Imaging

Publication Year: 2007

DOI:
10.1007/s00259-007-0659-z

PMCID:
PMC2668561

PMID:
18157530

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Eur J Nucl Med Mol Imaging

Abbreviation: Eur J Nucl Med Mol Imaging

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Nuclear Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Activated fibroblasts in muscle sarcoidosis revealed by [<sup>18</sup>F]FAPI-74 PET.
Watabe T; Fukusumi T; Inohara H and 7 more (2023) - Transparency Score: 3/6
Adoption of Lutetium-<sup>177</sup> PSMA radioligand therapy for metastatic castration resistant pr…
Flegar L; Thoduka SG; Librizzi D and 9 more (2023) - Transparency Score: 3/6
A machine learning tool to improve prediction of mediastinal lymph node metastases in non-small cel…
Rogasch JMM; Michaels L; Baumgärtner GL and 10 more (2023) - Transparency Score: 5/6
Analysis of image data from the EuroNet PHL-C2 trial indicates a potential reduction in injected F-…
Tran-Gia J; Eberlein U; Lassmann M and 10 more (2023) - Transparency Score: 3/6
A phase I/II study of the safety and efficacy of [<sup>177</sup>Lu]Lu-satoreotide tetraxetan in adv…
Wild D; Grønbæk H; Navalkissoor S and 11 more (2023) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
1/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:

"We thank Alice van Dongen for her input. This study was financially supported by CIS bio International, Saclay, France. Zoledronic acid was kindly provided by Novartis, Stein, Switzerland."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025